Skip to main content
. 2018 Feb 6;9(17):13623–13636. doi: 10.18632/oncotarget.24426

Figure 7. Trastuzumab and 4D5 SDS-PAGE profile.

Figure 7

Coommasie blue-stained gel following SDS-PAGE of 2.5 µg of in-house expressed and purified trastuzumab (‘T’), clinical-grade trastuzumab (‘H’, Herceptin, Roche) and in-house expressed and purified 4D5 (‘4D5’) under non-reducing and reducing conditions.